Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biotech Ends October With Almost $1B in IPOs, $3B in M&A Activity, $3B in Possible Partnerships
Biotech Ends October With Almost $1B in IPOs, $3B in M&A Activity, $3B in Possible Partnerships
Biotech Ends October With Almost $1B in IPOs, $3B in M&A Activity, $3B in Possible Partnerships
Submitted by
admin
on October 31, 2010 - 11:35am
Source:
Seeking Alpha
News Tags:
Teva Pharmaceuticals
Sanofi
Pfizer
Pacific Biosciences
Merck
Macrogenics
Hikma
GSK
BMP Sunstone
biotech
Baxter International
Amicus Therapeutics
Immune Design
MedImmune
Headline:
Biotech Ends October With Almost $1B in IPOs, $3B in M&A Activity, $3B in Possible Partnerships
Do Not Allow Advertisers to Use My Personal information
